Fu Tan (福坦)福坦

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

每片含缬沙坦 氢氯噻嗪是一种在国家药监局注册认定的药品。该药品含有每片含缬沙坦、每片含缬沙坦 氢氯噻嗪、氢氯噻嗪-7c628c24等成分。

该药品关联的活性成分包括:每片含缬沙坦、每片含缬沙坦 氢氯噻嗪、氢氯噻嗪Qinglv Saiqin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:陕西白鹿制药股份有限公司Chinese legal name: 陕西白鹿制药股份有限公司。

您可以探索含有相同成分的其他药品:每片含缬沙坦-47f80e3e成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 福坦) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 氢氯噻嗪Qinglv Saiqin.

Manufacturers recorded for this product: 陕西白鹿制药股份有限公司Chinese legal name: 陕西白鹿制药股份有限公司.

Explore other medicines containing the same ingredient: 每片含缬沙坦 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 福坦Recorded Chinese name: 福坦
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 7粒7 capsules

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 陕西白鹿制药股份有限公司Chinese legal name: 陕西白鹿制药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20050429

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20050429

Manufacturer

Chinese legal name: 陕西白鹿制药股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20050429

生产企业

陕西白鹿制药股份有限公司(国产)

适应症

本品用于治疗单一药物不能充分控制血压的轻、中度原发性高血压。

用法用量

1.当用缬沙坦单一治疗不能满意控制血压时,用氢氯噻嗪25mg每日一次不能满意控制血压或发生低血钾时,可改用本品(含缬沙坦80mg/氢氯噻嗪12.5mg)每次片每日一次在服药2-4周内可达到最大的抗高血压疗效。 2.对于轻至中度的肾功能衰竭患者(肌酐清除率≥30ml/min)或轻至中度肝功能衰竭(非胆管性无胆汁淤积)的患者不需要调整

不良反应

在共包括1570名病人的两项对照临床试验中,730名病人接受缬沙坦与氢氯噻嗪的联合应用,报道的不良事件发生在中枢神经系统,上呼吸道,胃肠道。

禁忌

1.对本品中的任一成分或磺胺衍生物过敏。
2.妊娠(见妊娠和哺乳)。
3.严重的肝脏衰竭,胆汁性肝硬化或胆汁淤积。
4.严重的肾脏衰竭肌,肝清除率。

注意事项

1.对本品中的任一成分或磺胺衍生物过敏。
2.妊娠(见妊娠和哺乳)
3.严重的肝脏衰竭,胆汁性肝硬化或胆汁淤积。
4.严重的肾脏衰竭(肌肝清除率<30ml/min)或无尿。
5.难治性低钾血症、低钠血症或高钙血症行货症状性高尿酸血症(痛风或尿酸结石病史)。

贮藏

遮光,密封,在阴凉处保存

规格

7粒

证据Evidence

  • 批准文号: 国药准字H20050429
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.